MedPath

A retrospective study on changing antibiotics sensitivity pattern in NICU at tertiary care hospital

Not yet recruiting
Conditions
Other bacterial sepsis of newborn,
Registration Number
CTRI/2025/03/082292
Lead Sponsor
Bharati Vidyapeeth Medical College
Brief Summary

Summary

This five-year retrospective observational study aims to analyze the trends and patterns of antibiotic resistance among pathogens in neonatal sepsis at the Neonatal Intensive Care Unit (NICU) of Bharati Vidyapeeth Medical College Hospital, Pune. The primary objective is to assess the prevalence of bloodstream infections (BSI), urinary tract infections (UTI), and cerebrospinal fluid (CSF) infections in neonates admitted between January 2020 and December 2024. Secondary objectives include identifying the spectrum of causative pathogens, evaluating their antimicrobial susceptibility, and analyzing trends in antimicrobial resistance over the study period. All neonates with suspected sepsis who underwent blood, CSF, or urine culture testing during the study period will be included. Data will be collected retrospectively from the Department of Microbiology, focusing on culture positivity and antibiotic sensitivity. Statistical analysis will be conducted using SPSS v29 software, ensuring patient confidentiality. The study will provide critical insights into the evolving patterns of antibiotic resistance in neonatal sepsis, aiding in the optimization of empirical antibiotic therapy and infection control strategies. Findings from this research will help improve clinical management and antibiotic stewardship programs in NICUs, ultimately reducing neonatal morbidity and mortality associated with sepsis.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
1000
Inclusion Criteria

All neonates with suspected sepsis who undergo Blood, CSF, or Urine culture testing will be included.

Exclusion Criteria

Cases with no medical records available.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
to the neonatal unit in past 5 years.5 years from January 2020 till December 2024
To investigate the prevalence of5 years from January 2020 till December 2024
bloodstream infections (BSI), urinary tract infections (UTI), and cerebrospinal fluid (CSF) infections in neonates admitted5 years from January 2020 till December 2024
Secondary Outcome Measures
NameTimeMethod
To describe the spectrum of causative pathogens associated with neonatal sepsis.5 years from January 2020 till December 2024
To analyse trends in the prevalence andantimicrobial resistance of blood and CSF infections over the 5 year period.
To evaluate the antimicrobial susceptibility of the isolated pathogens to commonly used antibiotics.5 years from January 2020 till December 2024

Trial Locations

Locations (1)

Bharati Hospital

🇮🇳

Pune, MAHARASHTRA, India

Bharati Hospital
🇮🇳Pune, MAHARASHTRA, India
Dr Vikrant Deshmukh
Principal investigator
9096015474
vikrant.deshmukh40@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.